ZYMOPTIQ is a biotechnology startup founded in 2019 with headquarters in France. The company's motto, "Easier, faster, cheaper enzyme activity assay to understand and control your enzymes," encapsulates the essence of their offering. ZYMOPTIQ provides a disruptive analytic tool for characterizing, measuring, and assaying enzyme activities in a fast, simple, and affordable manner. Their enzymatic products are ready to use and very user-friendly, offering a new analytical solution for efficient enzymatic tests. The company received non-equity assistance investment from Eurasante on 22 January 2018, positioning itself as an attractive investment opportunity in the biotechnology sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Non Equity Assistance | Unknown | 1 | Eurasante | 22 Jan 2018 |
No recent news or press coverage available for ZYMOPTIQ.